Promoter methylation of the RASSF1A and DAPK genes was frequent in lung tumors from patients with primarily NSCLC, all of whom were Caucasian and from the Western Pennsylvania region. The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.